$Letter to the editor: 1-year clinical outcomes of bivalirudin vs. unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention$

Letter to the editor: 1-year clinical outcomes of bivalirudin vs. unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European heart journal. Cardiovascular pharmacotherapy 2024-05, Vol.10 (3), p.263-264
Hauptverfasser:	Rajab, Fatima, Mujahid, Aleena, Naseer, Bisal
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants - administration & dosage Anticoagulants - adverse effects Anticoagulants - therapeutic use Antithrombins - administration & dosage Antithrombins - adverse effects Antithrombins - therapeutic use Coronary Artery Disease - diagnosis Coronary Artery Disease - mortality Coronary Artery Disease - therapy Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - diagnosis Diabetes Mellitus, Type 2 - drug therapy Heparin - administration & dosage Heparin - adverse effects Heparin - therapeutic use Hirudins - administration & dosage Hirudins - adverse effects Humans Peptide Fragments - adverse effects Peptide Fragments - therapeutic use Percutaneous Coronary Intervention - adverse effects Percutaneous Coronary Intervention - mortality Recombinant Proteins - administration & dosage Recombinant Proteins - adverse effects Recombinant Proteins - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	2055-6837 2055-6845 2055-6845
DOI:	10.1093/ehjcvp/pvae010